Package 27241-112-05

{"route": ["ORAL"], "spl_id": "4e9e209a-9f87-41cb-a7ac-a1fbf5412995", "openfda": {"nui": ["N0000175599", "N0000020026"], "upc": ["0327241112034", "0327241111037", "0327241113031", "0327241114038"], "unii": ["742SXX0ICT"], "rxcui": ["402019", "403957", "484814", "757707"], "spl_set_id": ["7e4cdac1-42cc-4038-a86b-4890962ed806"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (27241-112-03)", "package_ndc": "27241-112-03", "marketing_start_date": "20190326"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (27241-112-05)", "package_ndc": "27241-112-05", "marketing_start_date": "20200617"}], "brand_name": "Tadalafil", "product_id": "27241-112_4e9e209a-9f87-41cb-a7ac-a1fbf5412995", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "27241-112", "generic_name": "Tadalafil", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tadalafil", "active_ingredients": [{"name": "TADALAFIL", "strength": "5 mg/1"}], "application_number": "ANDA209654", "marketing_category": "ANDA", "marketing_start_date": "20190326", "listing_expiration_date": "20261231"}